25 Oct. 2005
The fundamental issue is who owns the intellectual property rights over Tamiflu. The media reports suggest that the Swiss pharmaceutical company Roche will make billions.
While the drug is produced by Roche, it was developed by Gilead Sciences Inc.which owns the intellectual property rights. Gilead, which has maintained a low profile, has outsourced the production to Roche.
Donald Rumsfeld was appointed Chairman of Gilead Sciences, Inc. in 1997, a position which he held in the years prior to becoming Secretary of Defense.in the Bush adminstration. Rumsfeld had been on the Board of Directors from the establishment of Gilead in 1987.
As confirmed in a company press statement in 1997, Donald H. Rumsfeld assumed the position of Chairman, of GILEAD: :
"Gilead is fortunate to have had Don Rumsfeld as a stalwart board member since the company's earliest days, and we are very pleased that he has accepted the Chairmanship," Dr. Riordan said. "He has played an important role in helping to build and steer the company. His broad experience in leadership positions in both industry and government will serve us well as Gilead continues to build its commercial presence."
According to company statement: Gilead Science Inc "has been active in the development of inhibitors for the potential treatment and prevention of viral influenza and protease inhibitors for the potential treatment of HIV"
"The Company's research and development efforts encompass three interrelated programs: small molecule antivirals, cardiovascular therapeutics and genetic code blockers for cancer and other diseases. Gilead's expertise in each of these areas has also resulted in the discovery and development of non-nucleotide product candidates, including neuraminidase inhibitors for the potential treatment and prevention of viral influenza and protease inhibitors for the potential treatment of HIV"
Also find below an article published in the SF Chronicle, which points to the relationship between GILEAD and Roche in relation to the Rights over Tami Flu.
Michel Chossudovsky, Global Research, 26 Oct 2005
Who Owns the rights on Tamiflu
by Joseph Mercola
Finally, the pieces of the puzzle start to add up. Not long ago, President Bush sought to instill panic in this country by telling us a minimum of 200,000 people will die from the avian flu pandemic, but it could be as bad as 2 million deaths in this country alone.
This hoax is then used to justify the immediate purchase of 80 million doses of Tamiflu, a worthless drug that in no way shape or form treats the avian flu, but only decreases the amount of days one is sick and can actually contribute to the virus having more lethal mutations.
So the U.S. placed an order for 20 million doses of this worthless drug at a price of $100 per dose. That comes to a staggering $2 billion.
We are being told that Roche manufactures Tamiflu and, in a recent New York Times article, they were battling whether or not they would allow generic drug companies to help increase their production.
But if you dig further you will find that a drug was actually developed by a company called Gilead that 10 years ago gave Roche the exclusive rights to market and sell Tamiflu.
Ahh, The Plot Thickens...
If you read the link below from Gilead, you'll discover Defense Secretary Donald Rumsfeld was made the chairman of Gilead in 1997.
Since Rumsfeld holds major portions of stock in Gilead, he will handsomely profit from the scare tactics of the government that is being used to justify the purchase of $2 billion of Tamiflu.